Recalibrating Goals Can Lead to Better Outcomes in Academic/Industry Biomarker and Diagnostics Collaborations

Questions Answered

• Various relationships exist between academic institutions and industry engaged in biomarker and diagnostics development. What are the most common types of partnerships between academia and industry?
• Collaborations are focused on a variety of therapeutic areas, but some are much more common than others. Which therapeutic areas have the greatest number of biomarker/diagnostics collaborations?
• Industrial science and academic science have fundamentally different orientations, as well as different cultures and rules of conduct. What are the issues to consider before embarking on a partnership? What are the ingredients for a successful industry-academia relationship?

• Dealmaking assessment: Snapshot of academic/industry biomarker and diagnostics collaborations from January 2009 through June 2011.
• Sidebars: Innovative Medicines Initiative, Collaborative Models in the Pharmaceutical Industry.
• Commercial biomarker development: Creating a win-win for academia and industry; the negotiation process; caveats for successful relationships.
• Types of academia-industry relationships: Sponsorship, consultation, consortia, partnerships and collaborations, and spin-outs.